HL Pharma has over 20 years of industry knowledge and experience sourcing and supplying unregistered/unlicensed pharmaceuticals to hospitals, pharmacies, doctors, veterinarians and pharmaceutical wholesalers to ensure healthcare providers have access to an appropriate overseas registered product in the event the Australian registered product is in short supply or unavailable. HL Pharma hold licenses to import Schedule 2 (pharmacy medicine), S3 (pharmacist only medicine), S4 (prescription medicine/animal prescription medicine) S8 (controlled drug) and S9 (prohibited substance) HL Pharma is the partner of choice for the distribution of a number of niche pharmaceutical products.
Matt Hayward established HL Pharma in March 2014, having moved back to Australia after many years working in the UK. Matt has worked in many areas of the pharmacy profession including community pharmacy, hospital pharmacy, manufacturing, wholesaling and veterinary. He has extensive experience in the area of unregistered/unlicensed medicines supply, having owned his own company in the UK before it’s acquisition by United Drug of Ireland.
Market Data 
Markets 
